iBio, Inc. — Form 8-K
Filed July 17, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
iBio, Inc. filed an 8-K on July 17, 2026 disclosing Items 5.08 (Shareholder Nominations per Exchange Act Rule 14a-11) and 8.01 (Other Events). The filing provides no specific dollar amounts, counterparties, share counts, dates of transactions, or concrete details of what changed. The actual substance of the nominations and events is not contained in the header/index page provided.
Why this rating
No material facts disclosed in accessible text. Cannot assess business impact without event details. Likely routine governance filing.
Extracted items
- 5.08
- 8.01 other event
- 9.01 exhibits
See more from July 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.